Overnight, news broke that early trial human patients developed a “robust” immune response to a potential virus vaccine from Moderna. Stock futures soared over the news, and the stock market opened today higher as a result. But even despite an ongoing correlation between Bitcoin and the S&P 500, the cryptocurrency isn’t following this pump.
What’s the reason behind Bitcoin lagging on positive news that sent the stock market back to retest recent highs?
Early Stage Clinical Trials Show Robust Immune Response, Stocks Soar On The News
As soon as the pandemic hit, it became clear that the only way to stop its spread would be through a vaccine. Until one was ready, the world was likely stuck to abide by any lockdowns imposed by government officials.
Thus began an arms race between pharmaceutical giants under the gun from world leaders to come up with a working vaccine.
New peer-reviewed data shared by the New England Journal of Medicine revealed trials of Moderna’s promising vaccine is proving successful. And it sent stock market futures soaring as a result.
RELATED READING | HOW BITCOIN OUTPERFORMED BOTH THE S&P 500 AND NASDAQ IN FIRST HALF 2020
All of the 45 patients in the clinical trial produced neutralizing antibodies following treatment. Those that received a second dose exhibited a “robust” immune response.
Moderna also claims that the highest dose group experienced antibodies four times as much as survivors of the virus.
The share price of Moderna surged by over 15%, and stock market futures followed with strong gains. The Dow rose over 500 points pre-market, opening nearly 400 points higher at today’s market open.
Other assets, like cryptocurrencies, have meanwhile barely moved over the news. But why?
Bitcoin BTCUSD Versus S&P 500 SPX Comparison Line Chart | Source: TradingView
Why Isn’t Bitcoin’s Price Following The S&P 500 Pumping On Positive Vaccine Developments?
Over the last several months into 2020, the correlation between Bitcoin and the stock market has never been higher. In the above comparison between BTCUSD and the S&P 500, the correlation is uncanny.
Almost every peak and trough lines up well, aside from a few deviations. The latest deviation is occurring right now, as the S&P 500 reacts to the positive vaccine news, but Bitcoin continues to trend sideways.
Bitcoin has lacked its signature volatility over the last few weeks, leaving many investors and traders bored with the crypto asset. It’s turned many traders toward altcoins or even traditional markets like stocks.
RELATED READING | ECONOMIST WARNS OF 1929-LIKE SECOND LEG DOWN; WILL BITCOIN FOLLOW?
Bitcoin is becoming so stagnant, it isn’t even reacting to some of the most significant news since the outbreak first began: a vaccine is close to being ready, and is showing positive results.
While the boring sideways action may be frustrating or confusing for crypto investors, breaking free from any stock market correlation could be positive. The correlation between the two assets has only damaged Bitcoin thus far, letting the stock market take it down with each major crash.
The Black Thursday collapse delayed Bitcoin’s next bull market. With the virus out of the way and the stock market correlation gone, the cryptocurrency may finally be free to rally once again.
For now, even shaking the correlation hasn’t been enough to get the cryptocurrency to break out of this tight trading range.
Featured image from Shutterstock. origin »
Bitcoin fails to follow stock market rally as US biomedical firm Moderna, announces COVID-19...
The post Wall Street pumps following vaccine news while Bitcoin struggles appeared first on Coin Journal.
Coinspeaker MRNA Stock Up 18% in Pre-market, Moderna Has Good News about Its Coronavirus VaccineModerna (MRNA) stock is up over 18% in the pre-market after adding 4. 54% yesterday. The spike is attributed to the announcement that the coronavirus vaccine trial demonstrated a robust immune response.
Coinspeaker Moderna (MRNA) Stock Up Over 3% Today, mRNA-1273 Vaccine Passes Safety Test on AnimalsModerna (MRNA) is up today. The rise may be attributed to news that the company’s coronavirus vaccine has passed a safety test on animals.
Coinspeaker MRNA Stock Price Up 5% as Moderna to Start Testing COVID-19 Vaccine on 30,000 People in JulyModerna (MRNA) stock price is climbing to its ATH of $69 again. Currently, the shares are trading at around $63.
Coinspeaker GSK Stock Up 1. 25%, GlaxoSmithKline Plans to Make 1B Doses of Coronavirus Vaccine BoosterAfter GlaxoSmithKline announced its plans to produce 1 billion doses of a vaccine adjuvant next year, the GSK stock price started to rise.
Coinspeaker MRK Stock Up 1. 5% as Merck Set to Develop New Coronavirus VaccineMerck (MRK) stock price is up today as Merck announced a new partnership with the International AIDS Vaccine Initiative (IAVI) to develop a coronavirus vaccine.
Coinspeaker NVAX Stock Up Nearly 16% in Pre-market as Novavax Starts Coronavirus Vaccine TrialsNovavax (NVAX) has jumped by 16% in the pre-market. The company has announced human trials its COVID-19 vaccine.
Coinspeaker MRNA Stock Up 2. 69%, Is Coronavirus Vaccine Just Tip of the Iceberg for Moderna?Moderna (MRNA) stock price keeps rising today. Dr. Anthony Fauci is rather optimistic about the coronavirus vaccine candidate that is being developed by Moderna.
Coinspeaker AZN Stock Up 2%, AstraZeneca Gets $1B for Oxford University’s Coronavirus VaccineThe U. S. Biomedical Advanced Research and Development Authority has given AstraZeneca more than $1 billion in funding for the coronavirus vaccine.
Coinspeaker Moderna (MRNA) Stock Up 23% on Positive Data for Its Coronavirus Vaccine CandidateModerna said its experimental coronavirus vaccine demonstrated immune responses in some of the healthy volunteers who were vaccinated in a clinical study.
Coinspeaker Inovio (INO) Stock Rose 8% Yesterday, Up 5% Now as Hunt for COVID-19 Vaccine Goes OnInovio (INO) stock was jumped 8% yesterday, is in the green now after the company released its fiscal Q1 earnings report, while it is working on a coronavirus vaccine.
Coinspeaker MRNA Stock Up 10%, Moderna CEO Says Supply of Coronavirus Vaccine Will Be LimitedIt has become known that the supply of Moderna's coronavirus vaccine will be limited and the U.
Coinspeaker Moderna (MRNA) Stock Rises 10% after FDA Approves mRNA-1273 Vaccine for Phase 2 TrialPhase 2 trial of Moderna's coronavirus vaccine will shortly begin and enroll 600 participants.
Coinspeaker Inovio (INO) Stock Rises 5. 40% Today after 14. 55% Loss on FridayWhile the company has had great gains as it works on a COVID-19 vaccine, Inovio (INO) stock fell last Friday, was down in the-premarket today but is up as trading began.
Coinspeaker MRNA Stock Up 2%, Moderna Signs Deal to Ramp Up 1B COVID-19 Vaccine Doses a YearModerna is moving forward with its coronavirus vaccine. The company announced a deal with Lonza Group AG to manufacture 1 billion coronavirus vaccine doses a year.
Coinspeaker AstraZeneca (AZN) Stock Up 3%, Firm Teams Up with Oxford University on Coronavirus VaccineAs it has become known that AstraZeneca and Oxford University are working together on a coronavirus vaccine, the AZN stock price is rising.
Coinspeaker MRNA Stock Up 1. 32% Now, Moderna Proceeds for Phase 2 Testing of Coronavirus VaccineModerna Inc proceeds ahead for the Phase 2 clinical trial of its vaccine to fight with the coronavirus.
Coinspeaker NVAX Stock Jumped 25% Yesterday, Down 15% Now as Novavax Works on COVID-19 VaccineNovavax (NVAX) stock climbed 25% yesterday, adding to its current 2020 gains, as the company makes progress on its COVID-19 vaccine candidate.
Coinspeaker MRNA Stock Hikes 15% as Moderna Gets $483M Funding to Develop Coronavirus VaccineAfter Moderna announced it received $483 million in federal funding to speed up the development of the coronavirus vaccine, MRNA stock hiked 15%.
Coinspeaker JNJ Stock Up 1%, Jim Cramer Says Johnson & Johnson Is Ahead of COVID-19 Vaccine GameAccording to Jim Cramer, Johnson & Johnson COVID-19 vaccine candidate will help the public overcome fears of going out and spending money on entertainment.
British American Tobacco is hopeful it can create a coronavirus vaccine by June. U.S. stock market futures is up 1.1% in pre-market trading.
The post U.S. Futures Rise as ‘Mad Men’ Cigarette Giant Attempts Coronavirus Cure appeared first on CCN.com
Coinspeaker Johnson & Johnson Stock Up 7%, Human Testing of Coronavirus Vaccine to Begin by SeptemberJohnson & Johnson after the announcement of the test of its coronavirus vaccine, JNJ stock has continued to surge, rising over 7%.
Coinspeaker Moderna (MRNA) Stock Rises 3. 61% Today, Coronavirus Vaccine Results Are Still Months AwayModerna (MRNA) stock price has risen at the possibility of having a new coronavirus vaccine by the fall of this year.
Coinspeaker Johnson & Johnson (JNJ) Stock Down 2% Today, Coronavirus Vaccine Not Ready Until Year-EndJohnson & Johnson (NYSE: JNJ) stock lost 5. 64% on Friday and is 2. 33% down today.
Coinspeaker Moderna (MRNA) Stock Down 10. 48% after FDA Commissioner Comments on Vaccine TimelineModerna (MRNA) stock tanked by 10. 48% on Thursday. The slide followed FDA Stephen Huhn's statement that the COVID-19 vaccine is at least a year away.
Coinspeaker Coronavirus Vaccine Stock: Gilead Sciences or Moderna?Let's have a closer look at Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA) stocks as the companies are working on possible coronavirus vaccine.
Coinspeaker Moderna (MRNA) Stock Skyrocketed Over 19% Today After First Human Vaccine TestingModerna (MRNA) stock rocketed today after the biotech company dosed the first patient in a study of its coronavirus vaccine.
Coinspeaker Inovio (INO) Stock Crashes Over 30%, Citron Research Casts Doubt on Coronavirus VaccineInovio (INO) stock has now erased some of its YTD gains after Citron Research suggested the company was grandstanding.
Coinspeaker Biotech Stock Market Is Under Coronavirus Effect as Companies Are Working on VaccineAs most stock markets continue bleeding out due to the coronavirus outbreak, three biotech stocks have been defying the urge as the companies are working on a vaccine or a cure for the deadly coronavirus.
Coinspeaker Moderna (MRNA) Stock Climbs 23% as World Is Waiting for the Coronavirus Vaccine ResultsWith coronavirus outbreak spreading a lot of fears to the global investors, talks of a vaccine are bolstering the Moderna (MRNA) stock value.
Coinspeaker Moderna (MRNA) Stock Keeps Growing as First Batch of COVID-19 Vaccine Candidate SentModerna Inc (MRNA) stock has been skyrocketing since the company announced its mRNA COVID-19 vaccine has been successfully shipped to the National Institute of Allergy and Infectious Diseases.
Coinspeaker Moderna (MRNA) Stock Surges 20% on Monday, First Coronavirus Vaccine Sent for Human TrialsModerna (MRNA) stock price is increasing after the news that the first coronavirus vaccine is ready to be tested on humans.
Coinspeaker Stock Market Is in Green due to Earnings and Coronavirus Fears as Vaccine Is Not Tested YetBeing boosted by various factors, many stocks are climbing up while coronavirus fears are still growing.
Coinspeaker Johnson & Johnson Stock Is Rising as Company Is Going to Create Coronavirus VaccineJohnson & Johnson stock may incredibly increase as J&J chief scientific officer is 'pretty confident' the company can create a coronavirus vaccine.
Bitcoin price is consolidating above the $95,000 support zone. BTC must settle above the $100,000 level to start a fresh increase in the near term. Bitcoin started a fresh increase from the $94,200 zone.
Bitcoin price started a fresh upward move above $100,000. BTC is facing resistance at $103,000 and might aim for an upside break. Bitcoin started a decent upward move above the $100,000 zone. The price is trading below $103,200 and the 100 hourly Simple moving average.
Bitcoin price settled above the $100,500 resistance zone. BTC is consolidating gains and might aim for a fresh increase above the $105,000 zone. Bitcoin started a downside correction from the $106,800 zone.
Bitcoin price started a short-term downside correction from the $106,250 zone. BTC is consolidating above $100,000 and might aim for a fresh increase. Bitcoin started a downside correction from the $106,250 zone.
Bitcoin price is gaining pace above the $100,000 zone. BTC is rising and might accelerate higher if it clears the $102,000 zone. Bitcoin started a decent increase above the $100,000 zone. The price is trading above $100,500 and the 100 hourly Simple moving average.